Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

BIT:ICOS - Euronext Milan - IT0005455875 - Common Stock - Currency: EUR

12.68  -0.16 (-1.25%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ICOS. ICOS was compared to 13 industry peers in the Personal Care Products industry. While ICOS seems to be doing ok healthwise, there are quite some concerns on its profitability. ICOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ICOS was profitable.
ICOS had a positive operating cash flow in the past year.
In the past 5 years ICOS has always been profitable.
In the past 5 years ICOS always reported a positive cash flow from operatings.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of ICOS (4.62%) is worse than 61.54% of its industry peers.
ICOS has a Return On Equity of 10.18%. This is in the lower half of the industry: ICOS underperforms 61.54% of its industry peers.
The Return On Invested Capital of ICOS (8.42%) is worse than 61.54% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICOS is below the industry average of 11.95%.
Industry RankSector Rank
ROA 4.62%
ROE 10.18%
ROIC 8.42%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ICOS has a Profit Margin of 4.56%. This is comparable to the rest of the industry: ICOS outperforms 46.15% of its industry peers.
ICOS's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.80%, ICOS is doing worse than 69.23% of the companies in the same industry.
In the last couple of years the Operating Margin of ICOS has declined.
With a Gross Margin value of 19.19%, ICOS is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ICOS has declined.
Industry RankSector Rank
OM 8.8%
PM (TTM) 4.56%
GM 19.19%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICOS is still creating some value.
Compared to 1 year ago, ICOS has about the same amount of shares outstanding.
Compared to 5 years ago, ICOS has more shares outstanding
The debt/assets ratio for ICOS is higher compared to a year ago.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.37 indicates that ICOS is not in any danger for bankruptcy at the moment.
ICOS has a Altman-Z score (3.37) which is comparable to the rest of the industry.
The Debt to FCF ratio of ICOS is 8.40, which is on the high side as it means it would take ICOS, 8.40 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.40, ICOS is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.56 indicates that ICOS is somewhat dependend on debt financing.
ICOS has a Debt to Equity ratio (0.56) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 8.4
Altman-Z 3.37
ROIC/WACC1.22
WACC6.92%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

ICOS has a Current Ratio of 1.81. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
ICOS has a better Current ratio (1.81) than 84.62% of its industry peers.
A Quick Ratio of 1.19 indicates that ICOS should not have too much problems paying its short term obligations.
ICOS's Quick ratio of 1.19 is fine compared to the rest of the industry. ICOS outperforms 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.19
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

ICOS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.28%.
The Earnings Per Share has been growing slightly by 1.57% on average over the past years.
Looking at the last year, ICOS shows a small growth in Revenue. The Revenue has grown by 7.76% in the last year.
ICOS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.36% yearly.
EPS 1Y (TTM)-7.28%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%12.38%
Revenue 1Y (TTM)7.76%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%13.03%

3.2 Future

The Earnings Per Share is expected to grow by 12.49% on average over the next years. This is quite good.
The Revenue is expected to grow by 1.81% on average over the next years.
EPS Next Y14.63%
EPS Next 2Y14.57%
EPS Next 3Y12.49%
EPS Next 5YN/A
Revenue Next Year6.49%
Revenue Next 2Y6.46%
Revenue Next 3Y6.38%
Revenue Next 5Y1.81%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.36, the valuation of ICOS can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as ICOS.
When comparing the Price/Earnings ratio of ICOS to the average of the S&P500 Index (27.30), we can say ICOS is valued inline with the index average.
ICOS is valuated rather expensively with a Price/Forward Earnings ratio of 17.47.
ICOS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ICOS is cheaper than 61.54% of the companies in the same industry.
ICOS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.36
Fwd PE 17.47
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

69.23% of the companies in the same industry are more expensive than ICOS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ICOS is valued more expensive than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.67
EV/EBITDA 9.12
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ICOS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ICOS's earnings are expected to grow with 12.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.73
PEG (5Y)16.14
EPS Next 2Y14.57%
EPS Next 3Y12.49%

More info and screens

2

5. Dividend

5.1 Amount

ICOS has a Yearly Dividend Yield of 1.48%. Purely for dividend investing, there may be better candidates out there.
ICOS's Dividend Yield is slightly below the industry average, which is at 2.55.
Compared to the average S&P500 Dividend Yield of 2.37, ICOS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

ICOS pays out 37.10% of its income as dividend. This is a sustainable payout ratio.
DP37.1%
EPS Next 2Y14.57%
EPS Next 3Y12.49%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

INTERCOS SPA

BIT:ICOS (7/11/2025, 5:35:15 PM)

12.68

-0.16 (-1.25%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-04 2025-08-04
Inst Owners38.09%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.22B
Analysts86.67
Price Target17.52 (38.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP37.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.38%
PT rev (3m)-3.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.2%
Valuation
Industry RankSector Rank
PE 25.36
Fwd PE 17.47
P/S 1.15
P/FCF 35.67
P/OCF 12.29
P/B 2.56
P/tB 4.37
EV/EBITDA 9.12
EPS(TTM)0.5
EY3.94%
EPS(NY)0.73
Fwd EY5.73%
FCF(TTM)0.36
FCFY2.8%
OCF(TTM)1.03
OCFY8.13%
SpS11.05
BVpS4.95
TBVpS2.9
PEG (NY)1.73
PEG (5Y)16.14
Profitability
Industry RankSector Rank
ROA 4.62%
ROE 10.18%
ROCE 12.68%
ROIC 8.42%
ROICexc 11.19%
ROICexgc 16.95%
OM 8.8%
PM (TTM) 4.56%
GM 19.19%
FCFM 3.22%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexcg growth 3Y0.58%
ROICexcg growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 8.4
Debt/EBITDA 1.87
Cap/Depr 131.98%
Cap/Sales 6.12%
Interest Coverage 26.98
Cash Conversion 69.48%
Profit Quality 70.6%
Current Ratio 1.81
Quick Ratio 1.19
Altman-Z 3.37
F-Score5
WACC6.92%
ROIC/WACC1.22
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.28%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%12.38%
EPS Next Y14.63%
EPS Next 2Y14.57%
EPS Next 3Y12.49%
EPS Next 5YN/A
Revenue 1Y (TTM)7.76%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%13.03%
Revenue Next Year6.49%
Revenue Next 2Y6.46%
Revenue Next 3Y6.38%
Revenue Next 5Y1.81%
EBIT growth 1Y1.78%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year74.29%
EBIT Next 3Y27.67%
EBIT Next 5YN/A
FCF growth 1Y-28.87%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-3.62%
OCF growth 3Y17%
OCF growth 5Y3.39%